AMYLIN: PHYSIOLOGICAL ROLES IN THE KIDNEY AND A HYPOTHESIS FOR ITS ROLE IN HYPERTENSION

1. There are high‐affinity binding sites for amylin in the renal cortex associated with proximal tubules. These appear to represent seven transmembrane (heptatopic) receptors that are known to form ternary complexes with G‐proteins and activate second messenger systems.

[1]  M. Cooper,et al.  Amylin as a growth factor during fetal and postnatal development of the rat kidney. , 1998, Kidney international.

[2]  M. Voskuil,et al.  Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril , 1997, Journal of hypertension.

[3]  M. Voskuil,et al.  Increased density of renal amylin binding sites in experimental hypertension. , 1997, Hypertension.

[4]  D. Fanestil,et al.  Amylin, calcitonin gene-related peptide, and adrenomedullin: effects on thiazide receptor and calcium. , 1997, The American journal of physiology.

[5]  M. Cooper,et al.  Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus , 1997, Diabetologia.

[6]  M. Cooper,et al.  Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. , 1997, The American journal of physiology.

[7]  M. Cooper,et al.  Amylin--its role in the kidney. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  M. Hammerman.  New treatments for acute renal failure: growth factors and beyond. , 1997, Current opinion in nephrology and hypertension.

[9]  J. Fischer,et al.  Amylin mobilizes [Ca2+]i and stimulates the release of pancreatic digestive enzymes from rat acinar AR42J cells: Evidence for an exclusive receptor system of amylin , 1996, Peptides.

[10]  L. Cantley.  Growth factors and the kidney: regulation of epithelial cell movement and morphogenesis. , 1996, The American journal of physiology.

[11]  R. D. De Lisle,et al.  Metallothionein is a component of exocrine pancreas secretion: implications for zinc homeostasis. , 1996, The American journal of physiology.

[12]  T. Sanke,et al.  Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients , 1996, Diabetes.

[13]  P. S. St. John,et al.  Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. , 1996, The American journal of physiology.

[14]  Y. Dohi,et al.  Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. , 1996, Hypertension.

[15]  N. Aiyar,et al.  A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor (*) , 1996, The Journal of Biological Chemistry.

[16]  P. Sexton,et al.  Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin. , 1996, The American journal of physiology.

[17]  T. Lutz,et al.  Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. , 1996, The Canadian veterinary journal = La revue veterinaire canadienne.

[18]  A. Clark,et al.  Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. , 1995, Biochemical and biophysical research communications.

[19]  K. Catt,et al.  Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor (*) , 1995, The Journal of Biological Chemistry.

[20]  W. Banks,et al.  Permeability of the blood-brain barrier to amylin. , 1995, Life sciences.

[21]  C. Johnston,et al.  Amylin stimulates plasma renin concentration in humans. , 1995, Hypertension.

[22]  W. Colburn,et al.  Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue , 1995, Diabetes Care.

[23]  Hammerman Mr.  Growth factors in renal development. , 1995 .

[24]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[25]  M. Soley,et al.  Role of heterotrimeric G-proteins in epidermal growth factor signalling. , 1995, Cellular signalling.

[26]  T. Larson,et al.  Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine. , 1995, The American journal of physiology.

[27]  S. Bhavsar.  The selective amylin antagonist, AC413, prevents sucrose-induced increases in mean arterial pressure in rats. , 1995 .

[28]  J. Keiser,et al.  Endothelin antagonists improve renal function in spontaneously hypertensive rats. , 1995, Hypertension.

[29]  I. Reid,et al.  Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. , 1995, Biochemical and biophysical research communications.

[30]  C. Nast,et al.  Human acute tubular necrosis: a lectin and immunohistochemical study. , 1995, Human pathology.

[31]  K. Plate,et al.  Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. , 1995, The American journal of physiology.

[32]  M. Noble,et al.  Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros , 1995, The Journal of cell biology.

[33]  M. Hammerman.  Growth factors in renal development. , 1995, Seminars in nephrology.

[34]  G. Paxinos,et al.  In vitro autoradiographic localization of amylin binding sites in rat brain , 1994, Neuroscience.

[35]  B. Williams,et al.  Insulin resistance: the shape of things to come , 1994, The Lancet.

[36]  K. Jakobs,et al.  Unoccupied beta-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes. , 1994, European journal of pharmacology.

[37]  T. Rink,et al.  Amylin and Syndrome‐X , 1994 .

[38]  Bruce A. Yankner,et al.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus , 1994, Nature.

[39]  G. Cooper.  Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. , 1994, Endocrine reviews.

[40]  R. Safirstein,et al.  Gene expression in nephrotoxic and ischemic acute renal failure. , 1994, Journal of the American Society of Nephrology : JASN.

[41]  K. Alitalo,et al.  The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.

[42]  T. Rink,et al.  High affinity amylin binding sites in rat brain. , 1993, Molecular pharmacology.

[43]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[44]  P. Esbrit,et al.  Partial purification of a renotropic activity from plasma of uninephrectomized human subjects. , 1993, Nephron.

[45]  A. Wilks,et al.  NYK/FLK-1: a putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. , 1993, Oncogene.

[46]  C. Pollock,et al.  Compensatory renal hypertrophy: tubular cell growth and transport studied in primary culture. , 1993, Nephron.

[47]  L. Sorokin,et al.  Development of tubular and glomerular cells of the kidney. , 1992, Kidney international.

[48]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[49]  G. Breier,et al.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.

[50]  F. Toback,et al.  Regeneration after acute tubular necrosis. , 1992, Kidney international.

[51]  H. Abboud,et al.  Evolving role of growth factors in the renal response to acute and chronic disease. , 1992, Journal of the American Society of Nephrology : JASN.

[52]  H. Lodish,et al.  Expression cloning of an adenylate cyclase-coupled calcitonin receptor. , 1991, Science.

[53]  L. Rossetti,et al.  In Vivo Insulin Resistance Induced by Amylin Primarily Through Inhibition of Insulin-Stimulated Glycogen Synthesis in Skeletal Muscle , 1991, Diabetes.

[54]  H. Lodish,et al.  Expression cloning and characterization of a porcine renal calcitonin receptor. , 1991, Transactions of the Association of American Physicians.

[55]  H. Datta,et al.  Amylin-amide displays a proliferative effect on human umbilical vein endothelial cells. , 1990, Biochemical Society transactions.

[56]  H. Datta,et al.  Amylin‐amide: a new bone‐conserving peptide from the pancreas , 1990, Experimental physiology.

[57]  Michael W. Schwartz,et al.  Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells , 1990, Diabetes.

[58]  S. Kahn,et al.  Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. , 1990, Diabetes.

[59]  I. Macintyre.  AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS , 1989, The Lancet.

[60]  D. W. Hayden,et al.  Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. , 1988, The American journal of pathology.

[61]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. W. Hayden,et al.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[64]  L. Saxén,et al.  Induction of brush border antigens of the proximal tubule in the developing kidney. , 1980, Developmental biology.

[65]  W. Beierwaltes,et al.  Renal tubular reabsorption in spontaneously hypertensive rats. , 1979, The American journal of physiology.

[66]  C. Lambert,et al.  Length-dependent activation of in situ canine skeletal muscle. , 1979, The American journal of physiology.

[67]  W. Beierwaltes,et al.  Renal and nephron hemodynamics in spontaneously hypertensive rats. , 1979, The American journal of physiology.

[68]  B. Unsworth,et al.  Evidence for a two-step mechanism operating during in vitro mouse kidney tubulogenesis. , 1972, Journal of embryology and experimental morphology.

[69]  C. Grobstein.  Inductive interaction in the development of the mouse metanephros , 1955 .

[70]  E. Opie.  ON THE RELATION OF CHRONIC INTERSTITIAL PANCREATITIS TO THE ISLANDS OF LANGERHANS AND TO DIABETES MELUTUS , 1901, The Journal of experimental medicine.